Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preservative-Free Triamcinolone Acetonide with PDT in Neovascular AMD
NCT00100009Phase 3Completed
- Sponsor
- National Eye Institute
- Start
- Dec 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone acetonide in neovascular age-related macular degeneration (NVAMD), sponsored by National Eye Institute. Started Dec 2004; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
neovascular age-related macular degeneration (NVAMD)
Beyond the preview
Go deeper on NCT00100009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00100009.